Actively Recruiting
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Led by Mayo Clinic · Updated on 2025-11-12
50
Participants Needed
1
Research Sites
517 weeks
Total Duration
On this page
Sponsors
M
Mayo Clinic
Lead Sponsor
N
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).
CONDITIONS
Official Title
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with neurodegenerative apraxia of speech according to clinical criteria at Mayo Clinic
You will not qualify if you...
- Having other illnesses that could explain speech or language problems, such as traumatic brain injury, strokes, or developmental syndromes
- Pregnant, postpartum, or breastfeeding women
- Women who can become pregnant must have a pregnancy test within 48 hours before the PET scan
- Contraindications to MRI such as metal in the head or cardiac pacemaker
- Severe claustrophobia
- Conditions that may interfere with brain imaging like structural abnormalities, subdural hematoma, or brain tumors
- Medically unstable or on medications affecting brain structure or metabolism, such as chemotherapy
- Lack of an informant or refusal to consent to research participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
S
Sarah Boland, CCRP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here